Sells medical rehabilitation devices, including robotic exoskeletons and anti-gravity systems, to people with mobility impairments, rehabilitation centers and hospitals.
10-K for FY2025, filed Mar 18, 2026We are a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in…View ↗
In August 2023, we made our first acquisition to supplement our internal growth when we acquired AlterG, a leading provider of Anti-Gravity…View ↗
Development of our SCI Products took over a decade and was spurred by the experiences of our founder, Dr. Amit Goffer, who became a…View ↗
Product sales, the largest line, are counted when devices reach the customer; payors typically pay in 30 to 45 days, though CMS payments can take up to twelve months. AlterG leases earn revenue over the lease term, and service-type warranties over their service periods.
10-K for FY2025, filed Mar 18, 2026Revenue from Products sold to rehabilitation facilities and end users is recognized at a point in time once the customer has obtained…View ↗
Payment terms between the Company and its payors typically range between 30 to 45 days, depending on the type of payer, country of sale…View ↗
Revenue for the lease of AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. AlterG Anti-Gravity systems being…View ↗
In certain contracts, the company also provides a service-type warranty. Service-type warranty is accounted for as a separate performance…View ↗
10-K for FY2025, filed Mar 18, 2026
FY2025 revenue by product or service ↗$22M
10-K for FY2025, filed Mar 18, 2026
$22M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Sale of product
Sold outright
10-K for FY2025, filed Mar 18, 2026 |
78%
FY2022: 76%
|
Sale of product, FY2025
$17.2M Sources
|
Sold outright |
|
Lease Of Products
Recurring
|
8.1% |
Lease Of Products, FY2025
$1.8M Sources
|
Recurring |
|
Service And Warranty
Recurring
10-K for FY2025, filed Mar 18, 2026 |
14%
FY2022: 8.7%
|
Service And Warranty, FY2025
$3.1M Sources
|
Recurring |
U.S. facilities are approached through direct sales, and physicians and therapists refer individuals to home-use devices; professional and college sports teams also use AlterG systems. Outside the U.S., the company sells directly in Germany for ReWalk and Canada for AlterG, and through distributors in other markets.
10-K for FY2025, filed Mar 18, 2026
No. It lost $19.9M in FY2025.
10-K for FY2025, filed Mar 18, 2026
−$19.7MView ↗
10-K for FY2025, filed Mar 18, 2026
−$19.9MView ↗
10-K for FY2025, filed Mar 18, 2026
−$16.8MView ↗
10-Q for Q2 FY2026, filed Aug 14, 2026
−$11.5MView ↗
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
8-K, filed Aug 31, 2026
Effective August 31, 2026, Mr. Mark Grant will depart from his positions as the President and Chief Executive Officer of Lifeward Ltd. (the…View ↗
8-K, filed Aug 14, 2026
On August 14, 2026, the Company announced that Almog Adar will step down as the Chief Financial Officer of the Company. Mr. Adar will…View ↗
Growing. Revenue grew 3.7x in 4 years, from $6M in FY2021 to $22M in FY2025, about 39% a year.
Broader rehabilitation lineup
The older report described ReWalk exoskeletons, ReStore and distributed products; the latest report also includes AlterG anti-gravity systems acquired as a separate product line.
10-K for FY2022, filed Feb 23, 2023 10-K for FY2025, filed Mar 18, 2026We have sought to expand our product offerings beyond the SCI Products through internal development and distribution agreements. We have…View ↗
Competes with BTL Industries, Ekso Bionics, Rex Bionics, Cyberdyne, FREE Bionics, DIH, Wandercraft, and Bioness
10-K for FY2025, filed Mar 18, 2026In the market for anti-gravity rehabilitation systems, our AlterG systems compete with other treadmill-based rehabilitation technologies…View ↗
Loading...